Global mononucleosis diagnostic market is expected to witness an incremental growth over the forecast period due to increasing prevalence in mononucleosis epidemics globally and adoption of advanced diagnostic facilities. Mononucleosis is a communicable disease caused by Epstein Barr Virus, characterized by sore throat, fatigue and fever. Additionally, increasing health awareness and knowledge amongst patients, collateral effect of other disease epidemics having similar symptoms such as AIDS, strep throat, Lyme disease etc. are also expected to boost market growth in coming seven years. Similarly, adoption of sophisticated technology such as chemiluminescence technology, chromatographic immunoassay, immuno-latex test, Reverse Transcription Polymerase Chain Reaction test(RT-PCR) ,DNA probes, solidphase immunoassay facilitating accurate & precise results, qualitative detection, error minimization , reducing undesired use of antibiotics and time conservation is expected to upsurge the mononucleosis diagnostic market over the forecast period.
The overall mononucleosis diagnosis market is categorised on the basis of types of tests available such as monospot Tests, CBC Tests and Epstein Barr Virus (EBV) antibody tests. Monospot test constituted the largest share of the market as of 2014, owing to factors such as rapid detection of antibody, non interference with other tests, accurate results, and greater cost effectiveness. EBV antibody test market is gaining popularity and is expected to gain market share in future owing to failure of monospots test and better patient diagnosis.
Geographically, the entire mononucleosis market is segmented into North America, Europe, Asia Pacific, Latin America and MEA. As of 2014, North America constituted the largest share of the mononucleosis diagnosis market attributing to the factors such as, advanced healthcare infrastructure supporting novel testing, ,and increasing incidence rate of epidemics,. According to Centres for Disease Control and Prevention (CDC), majority of people in United States over all the age groups had been infected with Mononucleosis. It has also been stated that nearly half of the children are patients of mononucleosis responsible for initiation of the disease in the region. However, in Asia Pacific there is higher incidence of mononucleosis at an early age in comparison to developed regions where incidence takes place during adolescence. Thus, Asia pacific region is expected to exhibit lucrative growth rate over the forecast period attributing to increasing prevalence rate of epidemics along with supportive government initiatives for eradication of diseases, sanitary & living conditions especially in the emerging economies of India and China.
Some key players operating in this market are Daiichi, Digene, Hemagen, Meridian,Gene-Tac, Biotest, Abbott Laboratories, Bio-Rad, Genzyme, Roche,Zenith Johnson & Johnson, Becton Dickinson, Diasorin , Beckman Coulter, Alere. These companies are involved in extensive R&D with a view of increasing market penetration via new product development along with capitalizing the untapped opportunities in Asia Pacific region. Mergers and acquisitions and partnership agreements are further expected to provide lucrative growth platform to mononucleosis diagnostic market over the forecast period.
Grand View Research offers special pricing for:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.